The USDA said it does not regulate or have any plans to regulate plants that could otherwise have been developed through traditional breeding techniques.
Monsanto will have access to an updated genome-editing technology after signing a global licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 in agriculture. The CRISPR-Cpf1 system has potential to be a simpler and more precise tool for making targeted improvements in a cell’s DNA when compared to the […]
A non-exclusive global option and licensing agreement between Monsanto and Dow AgroSciences hopes to put the next generation of crop improvements into farmers’ hands. Dow AgroSciences’ EXZACT Precision Technology Platform for research and commercial development of new crop solutions will now be available across Monsanto Company’s research portfolio. EXZACT technology, which Dow AgroSciences has developed […]
A genome-editing technology that revolutionized the food science industry when it came out on the market in 2012 will now be part of Monsanto’s R&D. The leading global seed supplier recently announced that they grabbed the global licensing rights for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and […]